149 related articles for article (PubMed ID: 35916253)
1.
Li Y; Zhang W; Zhao J; Lai W; Zhao Y; Li Y; Qu J
Emerg Microbes Infect; 2022 Dec; 11(1):1973-1981. PubMed ID: 35916253
[TBL] [Abstract][Full Text] [Related]
2. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey].
Ceyhan İ; Özkara Ş; Güler MZ; Dulkar G; Altınsoy R; Vezir S
Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634
[TBL] [Abstract][Full Text] [Related]
3. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
5. Studies of antimicrobial resistance in rare mycobacteria from a nosocomial environment.
Pereira SG; Alarico S; Tiago I; Reis D; Nunes-Costa D; Cardoso O; Maranha A; Empadinhas N
BMC Microbiol; 2019 Mar; 19(1):62. PubMed ID: 30890149
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.
Chazel M; Marchandin H; Keck N; Terru D; Carrière C; Ponsoda M; Jacomo V; Panteix G; Bouzinbi N; Bañuls AL; Choisy M; Solassol J; Aubry A; Godreuil S
Ann Clin Microbiol Antimicrob; 2016 May; 15():30. PubMed ID: 27150659
[TBL] [Abstract][Full Text] [Related]
7. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study.
Ghosh R; Das S; De A; Kela H; Saha ML; Maiti PK
Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report.
Kuge T; Fukushima K; Matsumoto Y; Abe Y; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Kawasaki T; Matsuki T; Kagawa H; Motooka D; Tsujino K; Miki M; Miki K; Kitada S; Nakamura S; Iida T; Kida H
BMC Infect Dis; 2020 Nov; 20(1):888. PubMed ID: 33238934
[TBL] [Abstract][Full Text] [Related]
9. Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method.
Sharma M; Malhotra B; Khandelwal S
Indian J Med Microbiol; 2021 Jul; 39(3):306-310. PubMed ID: 33846029
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
[TBL] [Abstract][Full Text] [Related]
12.
Brown-Elliott BA; Rubio A; Wallace RJ
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
[TBL] [Abstract][Full Text] [Related]
13. Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India.
Goswami B; Narang P; Mishra PS; Narang R; Narang U; Mendiratta DK
Indian J Med Microbiol; 2016; 34(4):442-447. PubMed ID: 27934821
[TBL] [Abstract][Full Text] [Related]
14. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.
Brown-Elliott BA; Woods GL
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31315954
[TBL] [Abstract][Full Text] [Related]
16. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Chu HS; Chang SC; Shen EP; Hu FR
PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
18. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
[TBL] [Abstract][Full Text] [Related]
19. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
[TBL] [Abstract][Full Text] [Related]
20. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
Kim SY; Shin SJ; Jeong BH; Koh WJ
BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
